Linganisha mbinu

	Jaribio la shamba la kiwango kimoja cha upofu	Jaribio la Kisayansi la Kidhibiti cha Machafuko lenye Kufunikwa kwa Upande Mmoja
Nyanja	Muundo wa Majaribio	Muundo wa Majaribio
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	Mid-20th century (blinding conventions formalised 1940s–1960s)	1948 (formalized); single-blind variant established in mid-20th century clinical trial methodology
Mwanzilishi	Established practice in experimental social science and clinical research; codified by Campbell & Stanley (1963) and Shadish, Cook & Campbell (2002)	Bradford Hill and colleagues (MRC streptomycin trial, 1948); blinding conventions codified in CONSORT guidelines
Aina	Controlled field experiment with partial blinding	Experimental design — blinded randomized trial
Chanzo asilia	Shadish, W. R., Cook, T. D., & Campbell, D. T. (2002). Experimental and Quasi-Experimental Designs for Generalized Causal Inference. Houghton Mifflin. ISBN: 978-0395615560	Schulz, K. F., Altman, D. G., Moher, D., & CONSORT Group. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ, 340, c332.
Majina mbadala	single-masked field experiment, field experiment with single blinding, single-blind natural-setting trial	single-masked RCT, single-blind RCT, single-blind trial, SB-RCT
Zinazohusiana	6	5
Muhtasari	A single-blind field experiment combines real-world experimental conditions with partial blinding: either participants or outcome assessors — but not both — are kept unaware of treatment assignment. This design reduces demand characteristics or observer bias while preserving ecological validity, making it a practical middle ground when full double-blinding is logistically infeasible in naturalistic settings.	A single-blind randomized controlled trial (SB-RCT) is a rigorous experimental design in which participants are randomly assigned to treatment or control conditions while remaining unaware of which condition they have received. Investigators, outcome assessors, and data analysts are not blinded. By masking participants, the design eliminates placebo and nocebo response biases on the participant side, while preserving investigator flexibility to administer and monitor the intervention.